# User Stage B Review Packet

## Recommendation

`PASS_RECOMMENDED` at `TIER_B_Q2_VIABLE`, with evidence limited to `PRELIMINARY_SUPPORT`. If mainline accepts the package, the correct holding state is `PENDING_USER_STAGEB_REVIEW`. Stage B remains unauthorized until you explicitly approve it.

## What revision1 established

- The frozen NDV contract is now faithfully implemented.
- Full-vector and compact quotients both preserve the exact optimum in 19,440 formal instances plus JOB 4a.
- Compact reproduces the full-vector equality classes with `0` recorded mismatches.
- The audited bound has `0 / 404,479` overestimates.
- Primary and replay agree on every nonvolatile field.
- The compact frozen representation retains `601,569 B` less canonical payload than exact, a `2.8743%` residual.

## What it did not establish

- Full vector is absorbed: `-32,749,534 B` retained residual and `-63,498,387` work units.
- Compact work residual is `-64,616,558`; both recorded compact runs are slower than exact.
- There is no optimizer speedup, logical-work reduction, process-RAM, cheap-bound, DBMS, natural-cost, executable-DPomega, unbounded-theorem, or global-novelty claim.
- JOB 4a is only a natural graph/equality-structure check with proxy costs.

## Why this still passes Stage A

The initial gate preregistered retained payload as an independent non-vacuity arm and allowed one compact same-equivalence pivot if full vector was absorbed. The compact path used that single allowance, kept the same information/action/object and exact optimum, paid its construction and audit costs, and left a positive deterministic persistent representation residual. The frozen STOP trigger therefore did not fire.

The result is downgraded from the owner's conditional Tier A to Tier B because the surviving residual is small and there is no end-to-end improvement. The missing direct compact construction, DPomega fidelity, theorem, and natural full-cost evidence are decisive Stage B risks, not completed contributions.

## Approval choice

Approve Stage B only if you want to spend the next phase testing whether the `2.87%` finite representation residual becomes a scalable, natural full-cost result. Approval should not be interpreted as acceptance of a speedup claim or as commitment to a paper.

- Current state recommended after mainline acceptance: `PENDING_USER_STAGEB_REVIEW`
- `stageb_user_approval_id`: `null`
- Stage B authorized: `false`
- Stage B executed: `false`

